Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Interest-Expense" stands at 7.58 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2023.
Shionogi & Co. Ltd.'s second quarter result of 1.82 Billion JPY for the item "Interest Expense" represents a decrease of -21.71 percent compared to it's first quarter result.
Also, Shionogi & Co. Ltd.'s second quarter result of 1.82 Billion JPY for the item "Interest Expense" represents a decrease of -34.07 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s second quarter result of 7.58 Billion JPY for the item "Interest Expense" represents a decrease of -11.07 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -33.68 percent compared to the value the year prior.
The 1 year change in percent is -33.68.
The 3 year change in percent is 404.06.
The 5 year change in percent is 83.35.
The 10 year change in percent is 3,669.15.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Expense | 280,205,508,085.11 |